SCHEMBL15869867

SCHEMBL15869867

CCOC(=O)c1cc(-c2cnccc2C)n(C)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.45
MMP13 P45452 3/20 0.44
MMP2 P08253 1/20 0.44
MMP14 P50281 1/20 0.44
KMT2A Q03164 2/20 0.43
ALDH1A1 P00352 2/20 0.43
MEN1 O00255 1/20 0.43
MAPT P10636 1/20 0.41
GAA P10253 1/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
CLK1 P49759 1/20 0.40
UBE2N P61088 1/20 0.40
HSD17B10 Q99714 1/20 0.40
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TSHR P16473 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17381180 0.87 MMP2 (0.43) MMP13MMP2MMP14ALDH1A1GAA
SCHEMBL15868129 0.83 FAAH (0.47) FAAHMMP13MMP2MMP14ALDH1A1
SCHEMBL21605639 0.83 FAAH (0.41) FAAHMMP13MMP2MMP14KMT2A
SCHEMBL15862193 0.83 ALDH1A1 (0.45) KMT2AALDH1A1MEN1GAAKDM4E
SCHEMBL20656276 0.82 FAAH (0.56) FAAHMMP13MMP2MMP14ALDH1A1
SCHEMBL15868156 0.80 FAAH (0.46) FAAHMMP13MMP2MMP14KDM4E
SCHEMBL15868122 0.80 SMN1; SMN2 (0.45) FAAHMMP13MMP2MMP14ALDH1A1
SCHEMBL15869830 0.80 CHRNA7 (0.47) FAAHMMP13MMP2MMP14KDM4E
SCHEMBL17375118 0.80 FAAH (0.52) FAAHMMP13MMP2MMP14KMT2A
SCHEMBL14799971 0.80 MMP13 (0.48) FAAHMMP13MMP2MMP14MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015197188-A1 PYRAZOLYL-BASED CARBOXAMIDES AS CRAC INHIBITORS Grünenthal GmbH (DE) 2015-12-30 WO disclosed
WO-2015197188-A1 PYRAZOLYL-BASED CARBOXAMIDES AS CRAC INHIBITORS Grünenthal GmbH (DE) 2015-12-30 WO disclosed
US-9078899-B2 Pyrazolyl-based carboxamides II GRUENENTHAL GMBH (DE) 2015-07-14 US disclosed
US-9078899-B2 Pyrazolyl-based carboxamides II GRUENENTHAL GMBH (DE) 2015-07-14 US disclosed
WO-2014108336-A1 PYRAZOLYL-BASED CARBOXAMIDES II AS CRAC CHANNEL INHIBITORS Grünenthal GmbH (DE) 2014-07-17 WO disclosed
US-20140194452-A1 Pyrazolyl-Based Carboxamides II Grünenthal GmbH (DE) 2014-07-10 US disclosed
US-20140194452-A1 Pyrazolyl-Based Carboxamides II Grünenthal GmbH (DE) 2014-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140194452-A1 Pyrazolyl-Based Carboxamides II AADAC, VDAC2, NLRP3 FAAH 1408/4885MMP13 2958/4885MMP2 4292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.